GALASSO, Gennaro
 Distribuzione geografica
Continente #
AS - Asia 14.661
NA - Nord America 12.085
EU - Europa 4.003
SA - Sud America 834
Continente sconosciuto - Info sul continente non disponibili 381
AF - Africa 168
OC - Oceania 11
Totale 32.143
Nazione #
US - Stati Uniti d'America 11.648
HK - Hong Kong 9.502
SG - Singapore 2.377
IT - Italia 1.713
CN - Cina 948
VN - Vietnam 850
BR - Brasile 587
RU - Federazione Russa 501
DE - Germania 411
UA - Ucraina 310
CA - Canada 226
FR - Francia 224
IE - Irlanda 200
TR - Turchia 160
BD - Bangladesh 155
FI - Finlandia 153
KR - Corea 145
GB - Regno Unito 130
IN - India 130
SE - Svezia 105
AR - Argentina 91
MX - Messico 79
JP - Giappone 68
PL - Polonia 54
ZA - Sudafrica 54
IQ - Iraq 49
ES - Italia 46
NL - Olanda 45
CO - Colombia 40
ID - Indonesia 34
EC - Ecuador 33
PK - Pakistan 29
SA - Arabia Saudita 27
MA - Marocco 24
PH - Filippine 24
CZ - Repubblica Ceca 23
VE - Venezuela 23
IL - Israele 21
JM - Giamaica 21
MY - Malesia 20
UZ - Uzbekistan 19
AT - Austria 18
CR - Costa Rica 18
KE - Kenya 17
PY - Paraguay 16
EU - Europa 14
GT - Guatemala 14
AE - Emirati Arabi Uniti 13
CL - Cile 13
EG - Egitto 13
HN - Honduras 13
JO - Giordania 13
NI - Nicaragua 13
KZ - Kazakistan 12
SC - Seychelles 12
LT - Lituania 11
TT - Trinidad e Tobago 11
SV - El Salvador 10
CW - ???statistics.table.value.countryCode.CW??? 9
PE - Perù 9
PR - Porto Rico 9
UY - Uruguay 9
DZ - Algeria 8
NP - Nepal 8
TN - Tunisia 8
AU - Australia 7
AZ - Azerbaigian 7
CH - Svizzera 7
IR - Iran 7
PA - Panama 7
BH - Bahrain 6
ET - Etiopia 6
HU - Ungheria 6
LB - Libano 6
LU - Lussemburgo 6
BE - Belgio 5
BO - Bolivia 5
OM - Oman 5
SR - Suriname 5
AL - Albania 4
AO - Angola 4
GP - Guadalupe 4
PS - Palestinian Territory 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BY - Bielorussia 3
EE - Estonia 3
GD - Grenada 3
HR - Croazia 3
KW - Kuwait 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BS - Bahamas 2
CI - Costa d'Avorio 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
GF - Guiana Francese 2
LV - Lettonia 2
Totale 31.735
Città #
Hong Kong 9.495
San Jose 1.511
Ann Arbor 1.442
Singapore 1.218
Chandler 683
Ashburn 670
Milan 637
Woodbridge 615
Dallas 583
Princeton 454
Jacksonville 442
Council Bluffs 441
Wilmington 413
Houston 371
Dong Ket 319
Beijing 292
Munich 224
New York 213
Dublin 198
Lauterbourg 183
Ho Chi Minh City 182
Rome 176
Los Angeles 166
The Dalles 155
Santa Clara 150
Hanoi 132
Boardman 127
Izmir 118
Moscow 102
Phoenix 101
Salerno 95
Andover 91
Turku 91
Nanjing 89
Naples 80
Memphis 77
São Paulo 70
Figino 67
Montreal 65
Tokyo 64
Pellezzano 63
Denver 60
Columbus 55
Chicago 54
Turin 50
Warsaw 48
Fairfield 46
Frankfurt am Main 44
Brooklyn 43
Orem 40
Seattle 35
Mestre 34
Toronto 34
Atlanta 33
Mexico City 33
Johannesburg 32
Da Nang 30
Poplar 30
Nanchang 29
San Francisco 29
Washington 27
Changsha 26
Dearborn 25
Norwalk 25
Stockholm 25
Düsseldorf 24
Amsterdam 23
Manchester 23
Philadelphia 23
Shenyang 23
Chennai 22
London 22
Nuremberg 22
Baghdad 21
Buffalo 21
Boston 20
Fisciano 20
Falls Church 19
Jiaxing 19
Querétaro 19
Haiphong 18
Rio de Janeiro 18
Seoul 18
Bologna 17
Brno 16
Florence 16
Tashkent 16
Ankara 15
Hebei 15
Miami 15
Nairobi 15
San José 15
Bari 14
Belo Horizonte 14
Brasília 14
Charlotte 14
Guatemala City 14
Mumbai 14
New Delhi 14
San Diego 14
Totale 24.179
Nome #
No-Reflow Phenomenon: Pathophysiology, Diagnosis, Prevention, and Treatment. A Review of the Current Literature and Future Perspectives. 1.033
Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome and Left Ventricular Outflow Tract Obstruction 949
589 THE EFFECT OF DAPAGLIFLOZIN ON SYMPTOMS, QUALITY OF LIFE AND ECHOCARDIOGRAPHIC PARAMETERS IN A REAL-WORLD POPULATION OF HFREF PATIENTS 912
Abdominal Aortic Aneurysm: Natural History, Pathophysiology and Translational Perspectives 862
TRANSCATHETER IMPLANTABLE DEVICES TO MONITORING OF ELEVATED LEFT ATRIAL PRESSURES IN PATIENTS WITH CHRONIC HEART FAILURE 628
Plasma miR-1-3p levels predict severity in hospitalized COVID- 19 patients 601
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions 545
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve 488
Acute Coronary Syndrome in patients with SARS-CoV-2 infection: Pathophysiology and Translational Perspectives 468
Predictors of Recurrent Ischemic Events in Patients With ST-Segment Elevation Myocardial Infarction 446
An active lifestyle improves outcome of primary angioplasty in elderly patients with acute myocardial infarction. 439
[Diagnosis of cardiovascular involvement in Fabry disease] 422
Infective endocarditis and diabetes mellitus: Results from a single-center study from 1994 to 2017 409
Implantable cardioverter-defibrillator explosion after gunshot: When the device protects not only from arrhythmic death|Esplosione di defibrillatore impiantabile in seguito a colpo d’arma da fuoco: quando il defibrillatore non previene soltanto la morte aritmica 323
An innovative Olive Pâté with nutraceutical properties 313
Exercise training and cardiac rehabilitation in covid-19 patients with cardiovascular complications: State of art 308
1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention 303
COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives 303
Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives 298
Technological Developments, Exercise Training Programs, and Clinical Outcomes in Cardiac Telerehabilitation in the Last Ten Years: A Systematic Review 276
Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials 265
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. 258
Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease 256
Effects of physical activity on endothelial progenitor cells (EPCs) 242
Analysis of regional right ventricular function by tissue doppler imaging in patients with aortic stenosis 236
Unrestricted use of endeavor resolute zotarolimus-eluting stent in daily clinical practice: a prospective registry 221
An active lifestyle prior to coronary surgery is associated with improved survival in elderly patients. 211
Abciximab in elderly with acute coronary syndrome invasively treated: effect on outcome. 206
Effect of an invasive strategy on outcome in patients ≥75 years of age with non-ST-elevation acute coronary syndrome 203
MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial infarction pAtieNts-(GUARDIAN) trial: Study design and rationale. 199
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy 198
Clinical outcome of patients with ST-elevation myocardial infarction and angiographic evidence of coronary artery ectasia 197
A new approach to percutaneous coronary revascularization in patients requiring undeferrable non-cardiac surgery. 193
Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: a meta-regression analysis of 30 randomized trials 190
Reperfusion correlates and clinical outcomes of right ventricular dysfunction in patients with inferior ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention 182
Adiponectin promotes endothelial progenitor cell number and function 181
Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials. 179
[Adipokines and coronary artery disease] 175
Nobori biolimus-eluting stent vs. permanent polymer drug-eluting stents in patients undergoing percutaneous coronary intervention 174
Arterial Hypertension in Patients with Takotsubo Syndrome: Prevalence, Long-Term Outcome, and Secondary Preventive Strategies. A Report from the Takotsubo Italian Network Register 172
Global longitudinal strain predicts outcome after MitraClip implantation for secondary mitral regurgitation 172
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial 171
Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvement 166
Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment 166
Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats 165
Valve-in-Valve Transcatheter Aortic Valve Replacement: From Pre-Procedural Planning to Procedural Scenarios and Possible Complications 164
Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis. 160
[Diabetes and ischemiccardiopathy] 160
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis 159
Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis 158
Pharmacotherapeutic considerations for the use of prasugrel and ticagrelor to reduce stent thrombosis in patients with acute coronary syndrome 157
Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction 150
Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. 148
Transradial versus transfemoral approach in patients undergoing percutaneous coronary intervention for acute coronary syndrome. A meta-analysis and trial sequential analysis of randomized controlled trials 148
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. 148
Angiogenic-regulatory network revealed by molecular profiling heart tissue following Akt1 induction in endothelial cells 147
[Is there an ideal stent for each type of coronarylesion?] 146
Adenosine-induced torsade de pointes complicating a fractional flow reserve measurement in a right coronary artery intermediate stenosis. 144
Long-term safety and efficacy of drug-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials. 143
Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion. 143
Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 142
In concomitant coronary and peripheral arterial disease,inflammation of the affected limbs predicts coronary artery endothelial dysfunction. 141
Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets 141
Relationship between contractile reserve, Tl-201 uptake, and collateral angiographic circulation in collateral-dependentmyocardium: implications regarding the evaluation of myocardial viability. 140
Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: A meta-analysis of randomized trials 140
Prognostic value of clinical, echocardiographic and angiographic indicators in patients with large anterior ST-segment elevation myocardial infarction as a first acute coronary event 140
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 140
Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation 139
Short-term Akt activation in cardiac muscle cells improves contractile function in failing hearts 138
Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction 137
Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: A 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study 137
Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease 137
Efficacy of automatic mode switching in DDDR mode pacemakers: The most 2 study 136
Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 135
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome 132
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 132
Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry 132
A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS 129
Clinical conditions and echocardiographic parameters associated with mortality in COVID-19 129
Isolated Valve Amyloid Deposition in Aortic Stenosis: Potential Clinical and Pathophysiological Relevance 129
Insulin-like growth factor-1 protects from vascular stenosis and accelerates re-endothelialization in a rat model of carotid artery injury 129
Vitamin D deficiency is independently associated with the extent of coronary artery disease 129
New perspectives for transcatheter aortic valve implantation: more than a "simple" alternative to surgery 128
Early stent thrombosis with bivalirudin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomised clinical trials 127
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction 127
Everolimus- versus first generation drug-eluting stents: the never-ending story of searching for a winner in the "limus family". 126
Immediate and long-term outcome of recanalization of chronic total coronary occlusions. 126
In vivo properties of the proangiogenic peptide QK. 126
Glucose control with insulin results in reduction of NF-kappaB-binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes 126
A novel promising frontier for human health: The beneficial effects of nutraceuticals in cardiovascular diseases 126
Rheolytic thrombectomy during percutaneous coronary interventionimproves long-term outcome in high-risk patients with acute myocardial infarction. 125
Mortality reduction with transradial approach in patients with ST-segment elevation myocardial infarction: Is the randomized evidence conclusive? 125
Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart. 124
Increased inflammatory status and higher prevalence ofthree-vessel coronary artery disease in patients with concomitant coronary andperipheral atherosclerosis. 124
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. 123
Endothelial dysfunction: Its clinical value and methods of assessment 123
Meta-analysis of randomized trials comparing the effectiveness of different strategies for the treatment of drug-eluting stent restenosis 123
Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention 123
Coronary stenting early before non-cardiac surgery: is the endothelial progenitor cell capturing coronary stent a solution? 122
Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique 122
Totale 22.809
Categoria #
all - tutte 92.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.166


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022808 0 0 0 0 41 25 32 40 103 99 97 371
2022/20231.561 145 135 49 192 213 319 2 139 270 7 60 30
2023/2024809 99 114 52 28 54 104 19 38 5 36 32 228
2024/20252.549 61 33 41 117 90 232 429 136 357 160 483 410
2025/202618.735 3.391 3.878 3.469 730 1.545 591 1.576 342 652 1.130 377 1.054
2026/20272.755 481 460 877 863 74 0 0 0 0 0 0 0
Totale 32.143